{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:56:57Z","timestamp":1791921417296,"version":"4.3.4"},"reference-count":48,"publisher":"Informa UK Limited","issue":"3","license":[{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"including study design, data collection"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2023,12,15]]},"DOI":"10.1080\/21645515.2023.2275453","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T12:21:21Z","timestamp":1699014081000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Safety and immunogenicity of three dose levels of an investigational, highly purified Vero cell rabies vaccine: A randomized, controlled, observer-blinded, Phase II study with a simulated post-exposure regimen in healthy adults"],"prefix":"10.1080","volume":"19","author":[{"given":"Sylvie","family":"Pichon","sequence":"first","affiliation":[{"name":"Sanofi","place":["Marcy-l\u2019\u00c9toile, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francoise","family":"Guinet-Morlot","sequence":"additional","affiliation":[{"name":"Sanofi","place":["Marcy-l\u2019\u00c9toile, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamshid","family":"Saleh","sequence":"additional","affiliation":[{"name":"Paradigm Research","place":["Redding, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Essink","sequence":"additional","affiliation":[{"name":"Meridian Clinical Research","place":["Omaha, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea-Clemencia","family":"Pineda-Pe\u00f1a","sequence":"additional","affiliation":[{"name":"Sanofi","place":["Marcy-l\u2019\u00c9toile, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annick","family":"Moureau","sequence":"additional","affiliation":[{"name":"Sanofi","place":["Marcy-l\u2019\u00c9toile, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Petit","sequence":"additional","affiliation":[{"name":"Sanofi","place":["Marcy-l\u2019\u00c9toile, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada-Maria","family":"Minutello","sequence":"additional","affiliation":[{"name":"Sanofi","place":["Marcy-l\u2019\u00c9toile, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,11,3]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003786"},{"key":"e_1_3_4_3_1","unstructured":"World Health Organization. Rabies epidemiology and burden of disease; 2022 [accessed 2023 Sept 1]. https:\/\/www.who.int\/teams\/control-of-neglected-tropical-diseases\/rabies\/epidemiology-and-burden."},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003709"},{"key":"e_1_3_4_5_1","unstructured":"World Health Organization. Rabies fact sheet; 2021 [accessed 2023 Sept 1]. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/rabies."},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000339"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/tbed.12168"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.05.021"},{"key":"e_1_3_4_9_1","volume-title":"Laboratory techniques in rabies","author":"Montagnon B","year":"1996","unstructured":"Montagnon B, Fanget B. Chapter 26: purified Vero cell vaccine for humans. In: Meslin F-X-K Koprowski H, World Health Organization, editors. Laboratory techniques in rabies. 4th ed. Geneva (Switzerland): WHO; 1996. p. 285.","edition":"4"},{"key":"e_1_3_4_10_1","unstructured":"World Health Organization. WHO consultation on public health and animal transmissible spongiform encephalopathies: epidemiology risk and Research requirements Geneva Switzerland 1-3 December 1999. Geneva: World Health Organization; 2000."},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.10.043"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.02.058"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.06.040"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.06.061"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.12.039"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2017.02.002"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/eb-2017-102701"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.06.061"},{"key":"e_1_3_4_19_1","first-page":"1","article-title":"Human rabies prevention\u2013United States, 2008: recommendations of the advisory committee on immunization practices","volume":"57","author":"Manning SE","year":"2008","unstructured":"Manning SE, Rupprecht CE, Fishbein D, Hanlon CA, Lumlertdacha B, Guerra M, Meltzer MI, Dhankhar P, Vaidya SA, Jenkins SR, et al. Human rabies prevention\u2013United States, 2008: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep. 2008;57:1\u201328.","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_4_20_1","unstructured":"World Health Organization. WHO expert consultation on rabies: third report. Geneva: World Health Organization; 2018."},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41118-020-00108-0"},{"key":"e_1_3_4_22_1","first-page":"535","article-title":"A rapid reproducible test for determining rabies neutralizing antibody","volume":"48","author":"Smith JS","year":"1973","unstructured":"Smith JS, Yager PA, Baer GM. A rapid reproducible test for determining rabies neutralizing antibody. Bull World Health Organ. 1973;48:535\u201341.","journal-title":"Bull World Health Organ"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2019.06.017"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a118408"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-020-2740-6"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/v13081516"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.1.5.2110"},{"key":"e_1_3_4_28_1","article-title":"Safety and immunogenicity of purified Vero cell rabies vaccine versus purified chick embryo cell rabies vaccine using pre-exposure and post exposure regimen among healthy volunteers in San Lazaro hospital","volume":"52","author":"Miranda E","year":"2014","unstructured":"Miranda E, Lacuesta TL, Lacuesta V, Suquila J, Manalo M, Dimaano E . Safety and immunogenicity of purified Vero cell rabies vaccine versus purified chick embryo cell rabies vaccine using pre-exposure and post exposure regimen among healthy volunteers in San Lazaro hospital. Philip J Inte Med. 2014;52:1\u20137.","journal-title":"Philip J Inte Med"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis384"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix791"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1307483"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2018.1473765"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2027714"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1656967"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1854000"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-10281-1"},{"key":"e_1_3_4_37_1","first-page":"491","article-title":"Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of post-exposure rabies vaccination under the 2-1-1 regimen: a field trial in Indonesia. MAS054 clinical investigator group","volume":"76","author":"Lang J","year":"1998","unstructured":"Lang J, Simanjuntak GH, Soerjosembodo S, Koesharyono C. Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of post-exposure rabies vaccination under the 2-1-1 regimen: a field trial in Indonesia. MAS054 clinical investigator group. Bull World Health Organ. 1998;76:491\u20135.","journal-title":"Bull World Health Organ"},{"key":"e_1_3_4_38_1","first-page":"1","article-title":"An evaluation of the safety and potency of equine rabies immunoglobulin through measurement of suppression on vaccine-induced antibody production among healthy volunteers","volume":"52","author":"Salva EP","year":"2014","unstructured":"Salva EP, Dimaano EM, Villarama JBR, Suquila JT. An evaluation of the safety and potency of equine rabies immunoglobulin through measurement of suppression on vaccine-induced antibody production among healthy volunteers. Philip J Inte Med. 2014;52:1\u20137.","journal-title":"Philip J Inte Med"},{"key":"e_1_3_4_39_1","unstructured":"Soentjens P Declercq S. Prophylaxie post-exposition contre la rage Institute of tropical medicine Antwerp September 2020. 2020."},{"key":"e_1_3_4_40_1","unstructured":"UK Health Security Agency. Administration of rabies vaccine and iImmunoglobulin. 2022."},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.3390\/v13071252"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-021-11515-4"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.08.054"},{"key":"e_1_3_4_44_1","first-page":"1","article-title":"Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices","volume":"59","author":"Rupprecht CE","year":"2010","unstructured":"Rupprecht CE, Briggs D, Brown CM, Franka R, Katz SL, Kerr HD, Lett SM, Levis R, Meltzer MI, Schaffner W, et al. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep. 2010;59:1\u20139.","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7118a2"},{"key":"e_1_3_4_46_1","first-page":"1009","article-title":"Poor immune response to rabies post-exposure prophylaxis: an attempt to understand the underlying mechanisms","volume":"1","author":"Audran R","year":"2016","unstructured":"Audran R, Depraetere G, Genton B, Spertini F, Uwanyiligira M, Mayor C, Thierry A, Zanoni R, Valliere S. Poor immune response to rabies post-exposure prophylaxis: an attempt to understand the underlying mechanisms. JSM Trop Med Res. 2016;1:1009.","journal-title":"JSM Trop Med Res"},{"key":"e_1_3_4_47_1","volume-title":"Presented at: the International Conference on Rabies in the Americas Meeting","author":"Morelli F","unstructured":"Morelli F, Augard C, Bourhy H, Bravo C, Coudeville L, Moore S, Quiambao B, Recuenco S. Immunogenicity of rabies vaccines in postexposure prophylaxis (PEP) or simulated PEP regimens: a systematic literature review and meta-analysis. Presented at: the International Conference on Rabies in the Americas Meeting; 2022 Oct 23\u201328; Quer\u00e9taro, Mexico."},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66754-8"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.4161\/21645515.2014.995059"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2023.2275453","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T14:40:52Z","timestamp":1749134452000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2023.2275453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,12,15]]}},"alternative-id":["10.1080\/21645515.2023.2275453"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2023.2275453","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-05-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2275453"}}